Shares of TXG opened at $7.14 on Tuesday. 10x Genomics has a 1 year low of $6.78 and a 1 year high of $37.74. The stock’s fifty day moving average price is $10.96 and its two-hundred day moving ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

TXG opened at $8.01 on Thursday. The stock has a market capitalization of $979.64 million, a P/E ratio of -5.27 and a beta of 2.01. 10x Genomics has a 12-month low of $6.78 and a 12-month high of ...

BofA analyst Michael Ryskin lowered the firm’s price target on 10x Genomics (TXG) to $12 from $16 and keeps a Neutral rating on the shares.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & ...

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ...

PLEASANTON, Calif., April 14, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced it will report financial results for the first quarter ...

10x Genomics (Nasdaq: NASDAQ:TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation ...

10x Genomics has an analyst consensus of Moderate ... there has been an increase of insiders selling their shares of TXG in relation to earlier this year. Most recently, in February 2025, Serge ...